Orchid Pharma's new Antimicrobial Solutions division aims to achieve a turnover of Rs 300 crore in three years, tackling ...

Creating a novel drug has always been a risky endeavor for biopharmaceutical companies. Developers and investors face ...

In the latest supply deal on the active pharmaceutical ingredients (API) front, Gilead Sciences has tapped South Korea’s ...

The medtech industry hopes to capitalise on increased awareness about the obesity space to promote multidisciplinary ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...

In terms of valuation, Traws Pharma Inc’s market capitalization stands at $7.79 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...

Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

Peoria County has secured more than $1.1 million in settlement cases with three major pharmaceutical companies filed during ...

As Novo Nordisk rakes in billions, Sen. Bernie Sanders and public health advocates demand answers on why U.S. patients are charged sky-high prices for life-saving drugs like Ozempic while generics ...

HAGUE—It is with great sadness that the family of Dr. Charles H. “Chuck” Tracy announces his death on September 12, 2024, ...